test

Developmental Therapeutics 

Debra Schwab Brandt DO

Departments & Organizations

Cancer Center, Yale: Developmental Therapeutics

Medical Oncology


Research Interests

Clinical Protocol Investigator: Phase II trial of cytoxan, vincristine, and fludarabine in patients with CLL and primary and refractory low grade non-hodgkin’s lymphoma.  more...


Education

  • D.O., DesMoines University, DesMoines, IA, 1991
collapsible-single-column-one-thumbnailphotobooksupi=10267172/WCF/News.svc/

Latest News

3

Edit Profile